Navigation Links
ELPHA 4 Conti

ProductsELPHA 4 Conti
Company Danmeter
Item ELPHA 4 Conti
Features 
  • ELPHA 4 Conti features pre-installed programmes with parameters based on the most up-to-date knowledge of the pelvic floor muscles.
  • On the one hand, the various type of muscle fibre (fast or slow twitch) can be targeted specifically, and on the other, the programme can be adjusted to enhance in treatment for individual requirements.
  • As something unique ELPHA 4 Conti offers symptomatic management of acute, chronic and cyclic pain syndromes with a dedicated pain relief programme of the pelvic floor and other muscle related pain with the use of surface electrodes.
Description ELPHA 4 Conti is a battery operated dual-channel therapy system designed for use in the treatment of conditions described below. ELPHA 4 Conti also includes a programme for treating pelvic pain. In STRESS- and faecal incontinence ELPHA 4 Conti provokes a contraction of the pelvic floor, so that the user can feel which muscles need exercising. In URGE incontinence, ELPHA 4 Conti helps normalise the micturition reflex, controlling the bladder function. The treatment is carried out in conjunction with the use of intra-vaginal or intra-rectal electrodes and the system can be used both in a clinic and at home.
Info Danmeter
Customer Service: +45 63 11 29 30
Web site: http://www.danmeter.dk/

Related medicine products :

1. ELPHA / ELPHA DL
2. Continuum Knee System
3. Continuum Primary Knee System
4. CGMS System Gold Continuous Glucose Monitoring
5. Continuous Wave II Arthroscopy Pump
6. DNA Engine Opticon Continuous Fluorescence Detection System
7. DNA Engine Opticon 2 Continuous Fluorescence Detection System
8. USA Elite System™ Rotating Continuous Flow Resectoscopes
9. Conti4000
10. Pelvicol Acellular Collagen Matrix (Continence)
11. Continuous Flow Cystoscopes
TAG: ELPHA Conti
Shepard Bipolar Forceps Straight
Shepard Bipolar Forceps Angled
McCullough Bipolar Forceps
Dean Tonsil Knife
Medicine Products:
(Date:12/2/2009)... Linemen especially likely to have metabolic syndr...HealthDay News) -- Exercise alone isn,t enough to ...g at higher risk for a medical condition that can ...Researchers studied linemen at Division I colleges...2 percent had metabolic syndrome, a group of condi...
(Date:12/2/2009)..., , VIRGINIA BEACH, Va., Dec. 2 /PRNewsw...garette. These smokeless cigarettes continue to gr...arket is now available at the PremiumEcigarette - ...ctronic cigarette - at the amazingly low price of ...for people to try the e-cigarette at a very low pr...
(Date:12/2/2009)..., , MONTREAL, Dec. 2 /PRNewswire/ - As pa...around the world, Wyeth, now a part of Pfizer, has...(IUs) of factor concentrates to the World Federati...on ever made to the WFH,s Humanitarian Aid Program...e WFH,s goals. ,, "This donation will directly ...
(Date:12/2/2009)..., , KNOXVILLE, Tenn., Dec. 2 /PRNewswire... presence in Southwest Florida with the acquisitio...LLC (EPN). Since January 2002, EPN has held an ex...ff the emergency facilities at the Downtown Naples...althcare Clinic. EPN also provides the staffing fo...
(Date:12/2/2009)..., EUROECHO 2009 is the official congress of the E...egistered branch of the European Society of Cardio...imaging will be presented. , New case reports w... latest evidence highlighting the role of this new... in imaging techniques, it is likely that non-inva...
Breaking Medicine News(10 mins):Health News:Oversized College Football Players May Face Heart Risks 2Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:Media alert: EUROECHO 2009 2
... regimen combining vinorelbine (Navelbine) and mit...rednisone is effective in the treatment of hormone... treatment should be offered to symptomatic patien...nts who had advanced prostate cancer, the investig...
...ion caused by the heart's inability to pump effici... and weaker. An estimated 5 million Americans ha...hin five years. It can be caused by high blood pre...ducing inflammation, helping to better control the...
...er whether hormone replacement therapy is safe and...tudy examines the pros and cons of this controvers... combined HRT therapy for five years. All the wome...uld not use HRT therapy because of the associated ...
...women more severely than men and greatly impacts t...University of Massachusetts Medical School, analyz...attention for chronic cough and a control group of... chronic cough group reported physical and extreme...
...nges from 10 percent to 25 percent, with the peak ...ars. Some reports suggest as many as 14 percent of...5 percent of women use antidepressants during preg... for pregnant women. However, most of these studie...
...ing a soft plastic tube or catheter into the linin...st undergo training for two weeks and are then abl...m the comfort of their home. Hemodialysis patients... kidney disease would choose home-based peritoneal...
Other Medicine News:Health News:A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer 2
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PRNe... including a late-breaking presentation on Tasigna...ronic myeloid leukemia, demonstrate the strength o...the care of patients. ,, The new data, at the ...eeting and Exposition, highlight the company,s cur...
(Date:12/1/2009)..., , TEMECULA, Calif., Dec. 1 /PRNewswire-Fir...Bulletin Board: PSTX) announced today that it has ...f Chief Financial Officer, Treasurer and Corporate...ting CFO since 2008. Prior to joining Patient Saf...t Finance, Chief Financial Officer, Treasurer and ...
(Date:12/1/2009)..., , REDONDO BEACH, Calif., Dec. 1 /PRNewswire...ounces their Elective Single Embryo Transfer (eSET...entive for patients with good embryo quality and a...he chance of twins by transferring a single embryo... technology today is reducing the number of multip...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2GSK Advisory 3A Warehouse Theft 55192 1GSK Advisory 3A Warehouse Theft 55192 2American Lung Association in Minnesota 3A Motorists Can Get 85 Cents a Gallon E85 Fuel in Woodbury Minn 55189 1AMERIGROUP Corporation to Host Investor Day 55187 1